Nancy Miller-Rich
DirectoratAldeyra Therapeutics· In proxies 2023–2025
Nancy Miller-Rich sits on 3 public boards.
Boards1
- Aldeyra TherapeuticsDirector · 5 yr on the boardIndependentCompensation—Paid as an executive
Board seats come from each company's latest proxy statement.
Experience
- Aldeyra TherapeuticsPublic company · 3 yr
- Director2023 – Present · 3 yrStock in role -90%
- Intercept Pharmaceuticals, Inc.Public company
- Director? – PresentNo stock prices for these years
- Kadmon HoldingsPublic company
- Director? – PresentNo stock prices for these years
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?